AMLN

Amylin Pharmaceuticals, Inc. (MM) (AMLN)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMLN
DataOraFonteTitoloSimboloCompagnia
09/08/201214:24Dow Jones NewsAstraZeneca: Bristol-Myers Squibb Completes Purchase of AmylinNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201222:11Edgar (US Regulatory)(25-NSE)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201215:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
08/08/201214:40Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201222:26Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
03/08/201200:03Dow Jones News2nd UPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201220:00Dow Jones NewsUPDATE: Bristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201218:30Dow Jones NewsBristol-Myers Executive Charged With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201218:17Dow Jones NewsU.S. Charges Bristol-Myers Executive With Insider TradingNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
02/08/201217:07Dow Jones NewsBristol-Myers Pension Executive Robert Ramnarine Arrested for Alleged Insider Trading -BloombergNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
01/08/201213:30Business WireBristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, ...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
31/07/201219:32ZacksSolid Quarter at ALKS, View Backed - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
30/07/201222:23Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
27/07/201202:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
26/07/201216:24Dow Jones NewsEvercore 2nd-Quarter Profit Climbs 19% On Higher Investment Banking RevenueNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201214:20Dow Jones NewsBristol-Myers Profit Falls 28%NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201214:00Dow Jones NewsBristol-Myers 2nd-Quarter Profit Falls 28% on Drug-Patent ExpirationsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
25/07/201211:39ZacksGeneric Plavix Hurts Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
23/07/201215:30ZacksEarnings Preview: Bristol-Myers - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
17/07/201220:10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201221:05Dow Jones NewsUPDATE: Icahn Appeals to Nonmanagement Directors at Forest LabsNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
12/07/201200:10Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
11/07/201219:03ZacksBristol-Myers/AMLN Deal Progresses - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201218:01PR Newswire (US)Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with It...NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201214:06Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201213:30Business WireBristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
10/07/201211:15ZacksAlkermes Upped to Outperform - Analyst BlogNASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
09/07/201218:51PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
07/07/201215:00Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
06/07/201214:53Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:AMLNAmylin Pharmaceuticals, Inc. (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AMLN

La tua Cronologia

Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network